Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Characterising Extravasated PET Doses; Evaluation of Metrics Associated with Topical Sensor Monitoring

Stephanie Sanchez and Geoff Currie
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3090;
Stephanie Sanchez
1Charles Sturt University Port Macquarie Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoff Currie
2Charles Sturt University Wagga Wagga Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

3090

Introduction: Partial extravasation of the radiopharmaceutical dose in positron emission tomography (PET) can undermine image quality and quantitation. The LARA topical sensor has been validated using a number of metrics to characterise injection quality following manual injection using 18F-FDG. An assessment of the performance of these metrics for autoinjector administration across a variety of radiopharmaceuticals has been undertaken.

Methods: A single site, single PET/CT scanner was used to characterise injections using a KARL100 autoinjector with standardised apparatus, flush volume and infusion rate using Rad-inject pump (1 min infusion followed by 2 syringe flushes) for 18F-FDG, 68Ga-PSMA and 68Ga-DOTATATE. 296 patients with topical application of LARA sensors were retrospectively analysed using conventional statistical analysis and in parallel, an artificial neural network. Three new metrics were developed (CEnd ratio, QIM1 and QIM2) to complement proprietary metrics in characterising extravasated injections (figure 1).

Results: The proprietary extravasation score greater than 200 demonstrated 33% sensitivity and 96.8% specificity in 18F-FDG studies (not validated in 68Ga studies). Extravasation amongst all radiopharmaceuticals was independently predicted by a tc50 greater than 1200 (100% sensitivity and 100% specificity), ndAvgN greater than 25 (100% sensitivity and 99.7% specificity), CEnd ratio greater than 2 (100% sensitivity and 100% specificity), QIM1 greater than 1600 (100% sensitivity and 100% specificity) or QIM2 greater than 1500 (100% sensitivity and 100% specificity). Furthermore, a ndAvgN cut-off of zero (0) classified abnormal TACs (venous retention but excluding extravasation) from normal TACs with a 95.5% sensitivity and 41.4% specificity.

Conclusions: Partial extravasation of PET doses are readily detected and differentiated using TAC metrics and these metrics could provide deeper insight into the impact of partial extravasation on image quality or quantitation. Further validation of key metrics and QIM are recommended in a larger and more diverse cohort. Funding: This project was funded by an ANSTO/ANZSNM Research Grant. 1 Figure 1: Annotated TACs for normal (A), normal with autoinjector multiple peaks and wider bolus (B), venous retention with resolution (C), and extravasation without resolution (D). 2

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Characterising Extravasated PET Doses; Evaluation of Metrics Associated with Topical Sensor Monitoring
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Characterising Extravasated PET Doses; Evaluation of Metrics Associated with Topical Sensor Monitoring
Stephanie Sanchez, Geoff Currie
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3090;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Characterising Extravasated PET Doses; Evaluation of Metrics Associated with Topical Sensor Monitoring
Stephanie Sanchez, Geoff Currie
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3090;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Gallium-68-αvβ3-Integrin Antagonist Peptidomimetic (Ga-68 αvβ3-IAC) Positron Emission Tomography for Imaging and Staging of Patients with Breast Cancer: A Pilot Study.
  • SPECT Imaging with Tc-99m-labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumorous Fibrosis
  • Artificial Intelligence is implemented as a tool in the daily workflow on the PET/MRI scanner to create an attenuation map for the correct PET image.
Show more

Technologist Poster Session

  • Assessment of Cardiac Amyloidosis with99mTc-Pyrophosphate (PYP) Quantitative SPECT
  • Changing methods of education under a pandemic - questionnaire survey about nuclear medicine examination classes at educational institutions -
  • Impact of different PET reconstruction algorithms on18F FDG SUV and MTV of tumor lesions
Show more Technologist Poster Session

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire